Viral Conjunctivitis Therapeutics Pipeline Market Review, H1 2016
COMPLETE REPORT DETAILS @ https://www.wiseguyreports.com/reports/393595-viral-conjunctivitis-pipeline-review-h1-2016
The, ‘Viral Conjunctivitis - Pipeline Review, H1 2016’, provides an overview of the Viral Conjunctivitis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Viral Conjunctivitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Viral Conjunctivitis and features dormant and discontinued projects.
For more information or any query mail at sales@wiseguyreports.com
The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
GET A SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/393595-viral-conjunctivitis-pipeline-review-h1-2016
Scope
- The report provides a snapshot of the global therapeutic landscape of Viral Conjunctivitis
- The report reviews pipeline therapeutics for Viral Conjunctivitis by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Viral Conjunctivitis therapeutics and enlists all their major and minor projects
- The report assesses Viral Conjunctivitis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Viral Conjunctivitis
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Viral Conjunctivitis
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Viral Conjunctivitis pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table Of Contents – Major Key Points
Viral Conjunctivitis - Companies Involved in Therapeutics Development 12
Adenovir Pharma AB 12
NanoViricides, Inc. 13
Panoptes Pharma Ges.m.b.H. 14
Shire Plc 15
Starpharma Holdings Limited 16
Viral Conjunctivitis - Therapeutics Assessment 17
Assessment by Monotherapy Products 17
Assessment by Target 18
Assessment by Mechanism of Action 20
Assessment by Route of Administration 22
Assessment by Molecule Type 24
Drug Profiles 25
APD-209 - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
astodrimer - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
EKCCide-I - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
PP-001 - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
SHP-640 - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
trisialic acid second generation - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Viral Conjunctivitis - Recent Pipeline Updates 33
Viral Conjunctivitis - Dormant Projects 37
Viral Conjunctivitis - Discontinued Products 38
Viral Conjunctivitis - Product Development Milestones 39
…. CONTINUED
For more information or any query mail at sales@wiseguyreports.com
GET EXCLUSIVE DISCOUNT ON THIS REPORT @ https://www.wiseguyreports.com/check-discount/393595-viral-conjunctivitis-pipeline-review-h1-2016
ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.
Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here
